The Puerto Rico Science, Technology and Research Trust awards a $100,000 NIH SBIR Phase I Cash Match to LifeGene-Biomarks, Inc. to conduct research and development under the project titled:  Precision methylation biomarkers for cervical cancer prevention in low resource settings in Latin America, funded by the National Cancer Institute.